Delivery Order SPE2DB22D2214-SPE2DB25FS6KH
- Not listed
- The Defense Logistics Agency awarded a $8,506 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes, with an ultimate completion date of August 18, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be performed from the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and a key...
- The Defense Logistics Agency awarded a $15,276.35 delivery order to AmerisourceBergen Drug Corp for Pediarix 0.5 ML syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract represents a single delivery of the pediatric vaccine product to support federal medical procurement needs. The award is not associated with a set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Pediarix 0.5 ML syringes valued at $7,613.09. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside contract. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $10,577.34 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Pediarix 0.5 mL syringes. This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. Performance will take place at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,299.69 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Pediarix 0.5 ML syringes. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The vaccine product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $5,344.50 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ML syringes. This firm fixed price contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a pediatric vaccine delivery under the agency's medical supply chain operations. The award utilizes no set-aside designation and was competitively awarded through open competition. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,759.00 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ml syringes. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Pediarix is a pediatric combination vaccine, and this order represents one of numerous pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $12,360.60 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes, a pediatric vaccine combination product. This firm fixed price delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,276.61 on August 8, 2025, for the supply of Pediarix 0.5 ML syringes. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 11, 2025, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's broader contractual...
- The Defense Logistics Agency awarded a delivery order valued at $6,931.68 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ML syringes. This firm fixed price delivery order, issued on August 19, 2025, with completion targeted for August 20, 2025, represents a pediatric vaccine procurement supporting military and federal healthcare supply chains. The award carries no set-aside designation, indicating it was competitively awarded through open procurement processes....
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6KHDelivery Order
The Defense Logistics Agency awarded a $8,543.67 delivery order to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price, competitively awarded delivery order represents a small-value transaction for a pediatric vaccine product to be performed at the vendor's location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal procurement processes. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical prime vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. The parent IDC enables the company to provide comprehensive global pharmaceutical support to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 9/2/25 |